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MODELING DOSE-RESPONSE AT LOW DOSE: A SYSTEMS BIOLOGY
APPROACH FOR IONIZATION RADIATION
Yuchao Zhao and Paolo F. Ricci  State Key Joint Laboratory of Environmental
Simulation and Pollution Control, School of Environment, Beijing Normal
University, Beijing, China; Holy Names University, Oakland, CA
 For ionization radiation (IR) induced cancer, a linear non-threshold (LNT) model at
very low doses is the default used by a number of national and international organizations
and in regulatory law. This default denies any positive benefit from any level of exposure.
However, experimental observations and theoretical biology have found that both linear
and J-shaped IR dose-response curves can exist at those very low doses. We develop low dose
J-shaped dose-response, based on systems biology, and thus justify its use regarding expo-
sure to IR. This approach incorporates detailed, molecular and cellular descriptions of bio-
logical/toxicological mechanisms to develop a dose-response model through a set of non-
linear, differential equations describing the signaling pathways and biochemical mecha-
nisms of cell cycle checkpoint, apoptosis, and tumor incidence due to IR. This approach
yields a J-shaped dose response curve while showing where LNT behaviors are likely to
occur. The results confirm the hypothesis of the J-shaped dose response curve: the main
reason is that, at low-doses of IR, cells stimulate protective systems through a longer cell
arrest time per unit of IR dose. We suggest that the policy implications of this approach are
an increasingly correct way to deal with precautionary measures in public health.
Keywords: ionizing radiation, dose-response, hormesis, cell-cycle checkpoint, incidence rates, precau-
tionary policy
INTRODUCTION
National federal laws direct cancer risk-based management of societal
choices regarding exposure to many substances, the production of energy,
and the commercialization of products: environmental protection (EPA),
occupational protection (OSHA), consumer protection (CPSC), drugs
and cosmetics use (FDA), and so on. A parallel approach occurs through-
out the OECD countries, including the European Union with its REACH
program. It is also well established that different agencies may use differ-
ent risk management approaches but the regulatory model of choice,
implicitly or explicitly, is the linear at low-doses (LNT) cancer dose-
response model. The regulatory models are characterized by a linear func-
tion in which response is proportional to dose (or dose rate), roughly at
risks below 0.01. However, particularly since 2005 (i.e., the US EPA Cancer
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Guidelines) there is an increasing legal recognition that alternative mod-
els to the LNT can be appropriate, provided sufficient evidence is available
to justify such choices. The problem remains: which of many competing
models is the superior one and why? This is an important question
because society faces a serious and very costly precautionary philosophy. It
consists of agencies having adopted a causal default assumption to regu-
late cancer risks at very low doses using models that have little current the-
oretical and empirical validity: these models are linear at very low doses.
The precautionary paradox is that these defaults result in regulatory
costs (measured in dollars) that can be disproportionate with the bene-
fits (the supposed reduction in the incidence of cancers) because – in the
vast majority of the instances known to us and documented by Calabrese
(Calabrese and Ricci, 2010) – the defaults deny any health benefit from
those low dose exposures even when these benefits are demonstrable
(this is summarized, for cancers, in Figure 1). As we summarize in Figure
1, the remarkable point in the choice of model is that, when the J-shaped
dose-response is correct, the regulatory concept of one in a million can-
cer risk becomes irrelevant. This is not an issue of uncertainty demand-
ing precaution: rather, it is the opposite situation: it is the paradox where
more certainty exists but it is neglected for the sake of a simplifying
assumption that cannot be demonstrated. This is a result from assessing
low exposures and infinitesimally low probabilities of cancer against gen-
erally much larger background cancer rates and by defining acceptable
risks that are stated as one in a million (individual excess lifetime cancer
risk) or as a range from one in a million to one in ten thousand. These
regulatory probabilities are used to set – given models of dose-response –
acceptable exposures to many carcinogens.
Choosing between different causal models for regulatory law and pol-
icy involves reasoning about the causal effect of exposure to low dose
rates of pollutants on the incidence of cancer: this causal analysis involves
complex biological pathways, genetics, molecular and cellular models
that are formalized mathematically as differential equations, which then
require statistical estimation. This is the essence of our work and its
demonstration of J-shaped behaviors at low doses. Fundamentally, there
is a bitter but necessary pill that must be swallowed: rigorous analysis is
the norm, rather than the exception. If an assumption of biological
behavior cannot be demonstrated – as is the case for the LNT (at very low
dose or dose rates) — its use should be an exception because that default
is not precautionary: it denies benefits when these exist.
Ionizing Radiations, LNT and Byphasic (Hormetic) Cancer Models
Ionizing radiation (IR) causes DNA damage that, if not adequately
repaired, results in pro-carcinogenic mutations and eventually cause can-
cer (Little, 2003). For IR induced dose response of mutation, investiga-
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tors usually use a linear non – threshold (LNT) model to estimate it
(Upton, 2002). Some epidemiological studies use a linear-quadratic
model in which radiogenic effects are linearly dependent at low doses
and then become quadratic at higher doses (Edwards, 1986): they cannot
admit J-shaped responses. Such models are used because sound, quanti-
tative, mechanism based computational models linking the initial IR-
induced damage with mutation and tumor formation are lacking. In
some instances, statistical models such as these have been able to repro-
duce a J-shaped dose-response model, but this occurs only when the num-
ber of data is sufficiently large (Ricci et al. submitted).
Radiologists have attempted to estimate health risks from low doses of
radiation for decades. Low dose IR exposure is particularly important for
health risk because environmental and occupational exposure to IR gen-
erally lies in the low dose region. The LNT and linear non-quadratic dose
response suggests that the biological effect of IR is proportional to dose
even at very low dose. However, studies at low dose IR regions pose chal-
lenges to the default linear dose-response assumption. These studies
include bystander effects, adaptive responses and low dose hypersensitivity
(Bonner, 2004; Mothersill and Seymour, 2004a; Mothersill and Seymour,
2004b). In the adaptive response, for example, the cellular transformation
frequency in the low dose region is reduced relative to controls (Azzam et
al. 1996; Redpath and Antoniono, 1998; Redpath et al. 2001). It usually
generates a J-shaped dose response at low dose, which is often referred to
as hormesis. Therefore, consideration of mechanistically-based dose-
response models for health risk has been found to be essential for assess-
ing the potential impact of the confounders on the response at low, envi-
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FIGURE 1. Biphasic (hormetic) Dose-response Model for Cancer Incidence the percent response in
the controls must be non-zero). Protection is “optimized” because it is greatest at a dose range fur-
thest away from a non-zero percentage response in the controls. The black dots identify exposure-
response points that are – or should be – included in any complete analysis otherwise the empirical
relationship based on the white dots) cannot be falsified. 
3
Zhao and Ricci: A systems biology model for low dose ionizing radiation
Published by ScholarWorks@UMass Amherst, 2014
A systems biology model for low dose ionizing radiation
459
ronmental doses (Bonner, 2004; Preston, 2005; Slikker et al. 2005).
Some radiation carcinogenesis models have been developed and
implemented in recent years to include mechanistic aspects up to some
level (Yakovlev and Polig, 1996; Wheldon et al. 2000; Ohtaki and Niwa,
2001; Heidenreich et al. 2002; Little et al. 2002; Mebust et al. 2002;
Moolgavkar and Luebeck, 2003; Pierce, 2003; Sachs et al. 2005). Some of
these are variants of clonal growth model (Heidenreich et al. 2002; Little
et al. 2002; Moolgavkar and Luebeck, 2003; Sachs et al. 2005). Others
include deterministic mathematical models (Wheldon et al. 2000), bio-
physical models (Mebust, et al. 2002), two-stage logistic models (Sachs et al.
2005) and stochastic process models (Yakovlev and Polig, 1996; Ohtaki
and Niwa, 2001). These models can include cellular birth-death processes
that are important determinants of dose-response behaviors in carcino-
genesis (Wheldon et al. 2000), and account for the effects of exposure on
genomic instability (Ohtaki and Niwa, 2001) and intercellular interaction
(Sachs et al. 2005). None of these models, however, describe the molecu-
lar-level mechanisms that define how IR exposure leads to alterations in
gene and protein expression and cellular outcomes.
Systems Approach
Recent reviews emphasize the new opportunities in dose response
modeling afforded by developments in computational systems biology
(Andersen et al. 2005a; Andersen et al. 2005b; Slikker et al. 2005). Systems
biology is defined as a comprehensive quantitative analysis of the manner
in which all the components of a biology system interact functionally over
time (Aderem, 2005). Putting toxicology in a systems biology context
involves the study of perturbations by environmental stressors on the
gene and protein expressions and linking these perturbations to toxico-
logical outcome. The incorporation of computational systems biology in
dose response modeling requires modular description of the functional
interactions of normal biology system and the perturbation of the normal
biology by stressors (Andersen et al. 2005b).
To incorporate systems biology approach into the development of
dose-response cancer models, simulation-based analysis is a distinct
branch: model behavior is first compared with experimental observa-
tions; models that survive initial testing can be then used to explore ques-
tions by targeted experimentation or by simulation for situation that are
not amenable to direct study (Kitano, 2002). Simulation-based study can
provide better linkage between dose response behavior and the underly-
ing molecular mechanism.
The objectives of this article are (1) to demonstrate a computational
systems biology approach to modeling IR dose response; (2) to explore
the pros and cons of this new approach through a practical study; (3) and
4
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to identify technical and practical challenges that arise in developing
these models.
METHODOLOGY
As an early example to integrate systems biology approach into dose
response modeling, this study integrates cell cycle checkpoint arrest by
IR-mediated DNA damage into IR induced transformation frequency in
two-stage clonal growth model (Moolgavkar and Knudson, 1981). We
take this approach and extend it below.
Integration of Computational Systems Biology Approaches in Dose
Response Modeling
Traditional dose response models generally implements a linear
structure and focuses on toxicology, i.e., the perturbation caused by envi-
ronmental stressor (Andersen, et al. 2005b). Figure 2 depicts the linkage
of physiologically based pharmacokinetic (PBPK) and pharmacodynamic
(PD) models to predict the effect of dose on response. PBPK models
describe exposure to the biologically effective dose and calculate the
form of the chemical/metabolite that is causative for the biological
mode of action describes early biological response to the active dose; and
the PBPD model describes how the toxic dose affects the body to cause
altered structure/function and ultimately disease.
Compared to the traditional approaches of dose response modeling,
computational systems biology approach implements a more complex
structure, as shown in Figure 3. Here, a modular approach was used to
illustrate this structure. Different modules describe different biological
processes. Module 1 captures the normal “biology” describing how nor-
mal biological functions arise from relevant biological elements that
together are called systems inputs; Module 2 captures the “perturbation”
and links the perturbation to altered biological targets (e.g. proteins)
that have direct influence on the normal biological system; Module 3
focuses on the “response” and disease outcome describing a process
which links lower level impaired function to higher level malfunctions
and diseases. The “biology” module can be any process directly damaged
by the mode of action and deemed to play a significant role on dose
response relationship. Therefore, incorporation of the maintenance of
normal biological function is the key advantage of integration of compu-
tational systems biology approach in dose response modeling. In this
manner, this approach enables a direct linkage between normal biology
and toxicology.
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Inclusion of Cell Cycle Model as the “Biology” Module
Cell cycle control is a basic function of a cell. Study of the dynamics
of cell cycle regulation is one area of systems biology. Both experimental-
ists and modelers have made considerable progress in this area (Kohn,
1998; Tyson et al. 2002; Qu, et al. 2003a; Qu, et al. 2003b; Blais and
Dynlacht, 2005; Chen et al. 2004; Sveiczer et al. 2004; Zwolak et al. 2005).
A normal cell cycle contains G1, S, G2, and M phases. S represents
DNA synthesis; M represents mitosis, which includes prophase,
metaphase, anaphase and telophase. S and M phases are separated by two
gaps: G1 and G2. Proper progression through the cell cycle is assured by
Internal 
dose 
Target 
organ 
dose
Biologic-
ally 
effective 
dose
Early 
biological 
response 
Altered 
structure/
function 
Disease Expo-
sure 
PBPK models Mode of Action PBPD models
FIGURE 2. Linear structure of linking PBPK and PD models to predict dose response. 
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(DNA repair)
(checkpoint
arrest/apoptosis)
(checkpoint control)
Exposure (IR)
Tissue dose
Biological interactions (ROS)
Perturbation (DSB, ATMP, p53P, p21, GADD45, 1433sigma)
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ultrasensitivity,
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3 
FIGURE 3. Schematic of integration of computational systems biology approaches in dose response
modeling. Module 1, “biology” module; Module 2, “perturbation” module; Module 3, “response”
module. Specific targets in current model are indicated in brackets. 
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“checkpoints” that guard crucial transitions: G1 to S transition (G1/S
checkpoint), G2 to M transition (G2/M checkpoint) and metaphase to
anaphase transition (spindle checkpoint). Checkpoint control is a surveil-
lance mechanism in cell cycle regulation that ensures suitable conditions
for the transitions to occur. The G1/S checkpoint makes sure that (1) cells
are large enough for a new round of DNA synthesis, (2) any damage suf-
fered by the DNA has been repaired, and (3) external conditions are
favorable for mitotic cell divisions. The G2/M checkpoint makes sure that
(1) DNA is fully replicated, (2) any new damage sustained by the DNA has
been repaired, and (3) the cell is large enough to divide. The spindle
checkpoint control ensures that chromosomes are properly aligned on the
mitotic spindle before the cohesins are degraded (Tyson et al. 2002).
IR, an important stressor, induces DNA damage and may disrupt cell
cycling through activating several proteins which have direct interactions
with cell cycle regulatory genes. These interactions lead to checkpoint
arrest and apoptosis; checkpoint arrest allows time for DNA to repair.
The delay at checkpoint lengthens the cell cycle and thus decreases cell
proliferation. Cell proliferation rate directly influences the number of
mutated neoplastic cells and is usually an essential factor in computa-
tional cancer modeling. Therefore, if checkpoint control is taken as the
normal biological function in Figure 3, checkpoint arrest and apoptosis
are perturbed functions caused by IR- mediated DNA damage, and DNA
repair is an adaptation process. Checkpoint arrest induced decrease in
cell proliferation rate will influence organism level response, i.e., cancer
incidence. Hence, it is essential to include a cell cycle model as a “biolo-
gy” module in systems biology approach based IR dose response model-
ing for cancer, to account for the effect of checkpoint arrest on cell pro-
liferation rate. The inclusion of a cell cycle model adds more realism to
the dose response modeling and helps explore the biological mecha-
nisms of specific phenomena (e.g. hormesis) at low doses, which is impos-
sible when the default model (LNT at low doses) is in fact an interpola-
tion from the experimental data to the (0,0) point on the dose and cumu-
lative probability of response coordinates.
Several mathematical cell cycle models have been developed to study
physiology of the normal cell cycle (Csikasz-Nagy et al. 2009; Han et al.
2005; Li, et al. 2009; Novak et al. 1998; Novak et al. 2001; Tyson and Novak,
2001; Qu et al. 2003a; Qu et al. 2003b; Qu et al. 2004; Zamborszky et al.
2007). In this study, cell cycle modeling serves as the module of “biology”
to support dose response modeling. Therefore, our implementation is
simplified to capture key nodes in the signaling pathway and remain
capable of modeling checkpoint control compared to existing cell cycle
models. Furthermore, to support the whole structure of the new
approach for dose response modeling (Fig. 3), the systems inputs of
checkpoint control must provide a direct linkage to toxicological pertur-
7
Zhao and Ricci: A systems biology model for low dose ionizing radiation
Published by ScholarWorks@UMass Amherst, 2014
A systems biology model for low dose ionizing radiation
463
bation. Therefore, appropriate identification of systems inputs in check-
point control is needed.
The identification of cell cycling inputs is based on the study of the cell
cycle model developed by Tyson (Tyson and Novak, 2001; Tyson et al.
2001; Tyson et al. 2002). Molecular antagonism or positive feedback, cell
growth and zero-order ultra-sensitivity were essential for checkpoint con-
trol (Tyson and Novak, 2001; Novak et al. 2007). With antagonism, a key
protein (A) would regulate cell cycle transition, A has a counteractive pro-
tein B which represses the activity of A and is also simultaneously inhibit-
ed by A. The mutual antagonism between A and B ensures an irreversible
transition. Furthermore, positive feedback can be taken as dual antago-
nism reaction and thus also assist irreversible transition. Perturbation sig-
nals (e.g. proteins activated by IR) directly interacting with A or B are thus
necessary nodes in the “perturbation” module. Progress from one cell
phase to next is promoted by cell growth (represented by cell mass m).
Based upon existing cell cycle models and associated mathematical analy-
sis, a zero-order ultra-sensitivity switch must exist in the antagonism reac-
tion in order to make the dynamics of the checkpoint regulation occur
(Tyson and Novak, 2001; Tyson et al. 2002, Kapuy et al. 2009). In zero-order
ultra-sensitivity circuit, which often involves an enzymatic inter-conversion
between a substrate and a product, switching occurs when the enzymes are
saturated by the substrate and/or product (Goldbeter and Koshland,
1981; Goldbeter and Koshland, 1984). Here the zero-order ultra-sensitivi-
ty switch is identified as the third element of systems input essential for
checkpoint control. Mathematical explanations of mutual antagonism and
for the zero-order ultra-sensitivity switch are shown in Results. Molecular
interactions of cell cycle regulation and the signaling pathways of IR
induced perturbation used in the current model are shown in Figure 4. In
brief, the antagonism reaction governing G1/S checkpoint in the model
takes place between CycE and Rb and the antagonism reaction governing
G2/M checkpoint in the model takes place between CycB and Wee1. Its
computer codes are available from the author4. A detailed biochemical
description of the signaling pathway and its associated mathematical
model are elsewhere (Zhao and Conolly, 2010).
Mathematical Model
The mathematical model consists of a set of nonlinear ordinary dif-
ferential equations (ODE) describing the rates of changes in protein
activities and cell mass. The absorbed dose rate of IR, represented by IRR,
is the input variable. In the model, the rate of change in cell mass is
described as a logistic function,
4Yuchao Zhao: mzhao1973@gmail.com
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(1)
where m = cell mass, µ = growth rate constant, and mmax = maximum
size to which a cell may grow if it does not divide.
Specific targets in the model have been identified for the Schematic
and are shown in brackets in Figure 3. ROS is taken as the product of ini-
tial biological interaction from IR exposure; Subsequent changes in DSB,
activated ATMp, p53p, p21, GADD45 and 1433sigma are downstream per-
turbations to the cell and will finally impair normal biological function –
checkpoint control.
In the following section, we link the IR response and cell cycle model.
Because G1/S and G2/M checkpoints are independent of each other,
dm
dt
m m m= −μ * * ( / )
max
1
RB
E2F
cycE
p27
cycB
IR
ROS
DSB
ATMp
p53p
p21
GADD45 1433sigma
BAX
BCL2
apoptosis
Caspase3
G1/S checkpoint
G2/M checkpoint
Wee1
Cdc25c
FIGURE 4. Signaling pathway of checkpoint control and IR-induced perturbation
(The antagonism reaction governing G1/S checkpoint in the model takes place between CycE and
Rb and the antagonism reaction governing G2/M checkpoint takes place between CycB and Wee1.
P27 and Cdc25 contribute to the two checkpoint transitions, respectively. To describe the perturba-
tion caused by IR, IR first induces double strand break (DSB), then DSB activates ATM by autophos-
phorylation. Phosphorylated ATM (ATMp) has repair function to DSB and it can also phosphorylate
and activate the transcriptional factor p53. Activated p53p then transcriptionally activates p21,
GADD45 and 1433 sigma. These are the genes that repress G1/S and G2/M transitions. p53 depend-
ent signaling also mediates the entry into the apoptotic pathway through regulation of Bax and Bcl-
2. Bax is pro-apoptotic and is transcriptionally activated by p53. Bcl-2 is anti-apoptotic and is tran-
scriptionally repressed by p53. Both Bax and Bcl-2 signal to caspases, which are proteases at the core
of the apoptotic machinery). 
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they are separately simulated. The combination of G1/S checkpoint and
“perturbation” module is referred to as “G1/S checkpoint-perturbation”
submodel; the combination of G2/M checkpoint and “perturbation”
module is referred to as “G2/M checkpoint-perturbation” submodel.
“Response”
As a “response” module in Figure 3, the impaired function simulated
by the IR perturbed cell cycle model was linked to a two-stage clonal
growth model (Figure 5) to investigate the dose response for IR induced
cancer. The linkage resides in direct relationship between checkpoint
arrest and cell proliferation rate. The two-stage clonal growth model used
for this analysis is identical in its biological structure to other two-stage
models (Moolgavkar and Knudson, 1981; Cohen and Ellwein, 1990),
describing populations of normal cells and of intermediate cells with one
mutation. Mutations occurs during the process of cell division, so that the
mutation parameter (µ) is a probability of mutation per cell division. A
tumor cell arises when an intermediate cell acquires a second mutation.
The equations of the two-stage clonal growth model are represented by
Equations (2), (3) and (4):
The mathematical model associated with the description in Figure 5 is:
(2)
(3)
(4)
Where:
p is the probability for a specified response (such as tumor)
N is the number of normal cells
αN is the division rate constant for normal cells (hour
-1)
βN is the death rate constant for normal cells (hour-1)
µN is the probability of mutation per division for normal cells
I is the number of intermediate cells
αI is the division rate constant for intermediate cells (hour
-1)
βI is the death rate constant for intermediate cells (hour-1)
µI is the probability of mutation per division for intermediate cells
The product of αN and µN represents mutational fraction per unit
time. The cell division rate αN, inverse of cell cycle time, is directly influ-
enced by checkpoint arrest. In this study, as an initial effort to implement
a computational systems biology approach in dose response modeling, we
focused on exploration of the relationship between IR dose and the
p tumor e I I I( ) = − ∫−1 α μ
dI
dt
I NI I N N= − +( )α β α μ
dN
dt
N N N= −( )α β
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quantity of αNµN. Neoplastic transformation is an important endpoint
associated with IR carcinogenesis (Redpath et al. 2001) and strongly cor-
related with mutation and cancer (Mills et al. 2003; Ishikawa et al. 2004).
Here αNµN is the surrogate of neoplastic transformation and is compared
to experimental data.
Simulation Procedure of Dose Response Relationship
Cell proliferation rate αN, inverse of cell cycle time, can be directly
simulated from the IR perturbed cell cycle model (Module 1 plus Module
2). When applying this computational systems biology approach, models
that survive initial testing can then be used to make predictions (Kitano,
2002). In another article (Zhao and Conolly, 2010.), the IR perturbed cell
cycle model was tested by comparing simulation results to extensive
experimental data. The consistency between the simulation and data pro-
vided justification for these subsequent analyses.
The cell cycle time is a function of the lengths of G1/S and G2/M
checkpoint arrests, as shown in Equation 5:
(5)
Where,
T = the cell cycle time under IR exposure
c = the normal cell cycle length without IR exposure, 
including G1, S, G2 and M phases, we assume it is 450 
time unit in the study
A1 = the G1/S checkpoint arrest time
A2 = the G2/M checkpoint arrest time
T = c + A + A1 2
Normal
cells (N)
Initiated
cells (I)
Cancer
cell
Tumor
(delay)
Division
( N)
Death/
differentiation
(β
α
N)
(αI)
(βI)
Mutation(μN )
Mutation(μI )
FIGURE 5. Description of two-stage cellular clonal growth model of cancer. 
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Time course plot or phase plane plot can be used to identify check-
point arrest time. In a time course plot, the key proteins regulating check-
point control have switch-like behaviors during G1 to S and G2 to M tran-
sitions (Zhao and Conolly, 2010). For example, when CycE jumps from a
lower state to a higher state, the G1 to S transition is activated; when CycB
jumps from a lower state to a higher state, the G2 to M transition is acti-
vated. The simulated switch-like behaviors of the proteins in G1/S check-
point, are shown in Figure 6. The protein behaviors under normal con-
ditions are indicated by basal activity; the protein behaviors under a cer-
tain IR exposure are indicated by induced activity. The switch can be used
to identify the G1 to S transition. Here, it is assumed that when CycE’s
activity increased greater than 0.1, G1 to S transition happens.
Checkpoint arrest delay can be further identified by the time lag between
the switches under IR exposure and normal conditions.
For a dynamical system with two variables x and y where 
and , 
phase plane plots are used to study how x and y change relative to each
other and to determine if the system has one or more steady states, i.e.,
f(x,y) = 0 and g(x,y) = 0. In the phase plane plot, a point on the x null-
cline is identified by fixing the value of y and running the computational
dy
dt
g x y= ( , )dx
dt
f x y= ( , )
0 50 1 00 1 5 0 20 0 2 5 0 30 0 3 50 40 0 4 50
0
0 .0 5
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0 .1 5
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o
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FIGURE 6. Time course of key protein activities from G1 to S transition. The protein behaviors under
normal conditions are indicated by basal activity; the protein behaviors under a certain IR exposure
are indicated by induced activity. In the transition, proteins, including cyclin E and its cyclin depend-
ent kinase CycE, Rb, and p27 have switch-like behaviors. 
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model to identify the corresponding steady state value of x. The entire x
nullcline is developed by repeating this steady state analysis over the
range of values of y that are of interest. The x nullcline is thus the set
defined by f (x,y) = 0, or in other words, the set of values of x at which the
system is at steady state for a range of values of y. Similarly, the y nullcline
denotes steady state values of y for a range of values of x, g (x,y) = 0.
Intersections of the x and y nullclines identify steady states of the entire
dynamical system. In a system with more than one steady state each steady
state is associated with a unique intersection of the nullclines. When the
dynamical system has more than two state variables, the variables not rep-
resented in the 2-dimensional plot are assumed to be in a “pseudo-steady
state”. That is, they change quickly with the variables of interest.
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FIGURE 7. Phase plane plots of CycE and Rb nullclines in G1/S checkpoint without a) and with b)
exposure to IR. 
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For example, Figure 7 shows a phase plane comparison of Rb and
CycE nullclines in G1/S checkpoints without and with exposure to IR
(Figs. 7a and 7b, respectively). As m (cell mass) increases from 0.33 to
0.39 to 0.5, the Rb nullcline moves to the left while CycE nullcline
changes only for small values of Cdh1 (Fig. 7a). At m = 0.33, the CycE and
Rb nullclines intersect 3 times. These intersections define two stable
steady states separated by an unstable steady state (the unstable steady
state is also called a saddle point). The two stable steady states correspond
to G1 and S. G1 is defined by high Rb and low CycE activities, while S is
defined by low Rb and high CycE activities.
As m increases from 0.33 to 0.39, the intersection of nullclines defin-
ing G1 state converges with the saddle point. As m increases to 0.5, the
intersection of nullclines that defines G1 disappears and the cell switches
into the S steady state. Thus, in the absence of exposure to IR, 0.39 is a
critical value of m. Here, we call it as critical mass. The G1/S transition
does not occur until the cell grows to this critical mass.
The critical cell size associated with the transition from G1 to S
increases in the presence of DNA damage subsequent to IR exposure
(Fig. 7b). In this case, with IRR = 0.1, the critical value of m is 0.65. Recall
that the critical value for the control case is 0.39. Activation of the G1/S
checkpoint is thus evidenced by the extra time spent in G1 as the cell
grows to this larger size (m = 0.65 vs. m = 0.39). This extra time provides
time for DNA repair and it can be calculated based on Equation (1).
The mutational rate µN is assumed to be a linear function of IR. Some
investigators have taken µN as a linear function of DNA damage, and DNA
repair may shape the relationship between µN and environmental dose to
nonlinear with a threshold or even “J-shaped” (Conolly et al. 2003). The
main purpose here is to explore how checkpoint arrest time influences
mutational fraction through proliferation rate, so an assumption of a sim-
ple linear relationship between µN and IR is appropriate. Therefore, µN
has the following function:
(6)
Where,
µbas = basal probability of mutation per division for normal cells, 
0.01 in the study
k = slope constant, three cases are evaluated in the study: 
5.27×10-5 (Case 1), 3.69×10-5 (Case 2), 2.64×10-5 (Case 3)
IRD = dose of IR, the product of IRR and exposure time
RESULTS
Simulated results of dose response relationship are described in this
section. Mathematical methods are then implemented to gain deeper
μ μN bas k IRD= + •
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biological insights into the mechanisms leading to the specific shapes of
the dose response.
The LNT states that even the minutest exposure is bad; the other, the
J-shape states that at those very same low levels, exposure is beneficial.
The issue in the use of dose-response models for cancer is the extrapola-
tion (or interpolation to 0,0 on the dose and response axes, for the lin-
earized multistage model, LMS) to where cancer risks of interest to regu-
latory law fall between 10-4 and 10-6. These (individual lifetime probabili-
ties) are orders of magnitude removed from the experimental data on
dose and response. The J-shaped model suffers from limitations in the
data: these are often not available because the traditional cancer bioassays
(NCI/NTP program) do not include a sufficient number of exposures
and responses to identify the J-shape, but can identify the ascending limb
(Figure 1) from background response. In this section we test these com-
peting models in terms of the results from biological modeling.
Simulation of Dose Response Relationships
For IRR = 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, G1/S and G2/M checkpoint
arrest time are identified using time course plot and phase plane plot,
respectively. The cell cycle time are calculated based on Equation 5. The
proliferation rate is calculated as inverse of cell cycle time. The IR dose is
calculated by IR dose rate multiplying cell cycle time. Table 1 summarizes
the estimated G1/S checkpoint arrest time, G2/M checkpoint arrest
time, cell cycle time, IR dose and proliferation rate. Then the mutational
fraction per hour, as surrogate for transformation frequency, is calculat-
ed by multiplying αN and µN for Cases 1, 2 and 3. Figures 8(a), 8(b) and
8(c) show the predicted shapes of dose response for IR induced transfor-
mation frequency for three cases, respectively. Figure 8 captured monot-
onically increasing (Case 1), nonmonotonically increasing or threshold
(Case 2) and J-shaped (Case 3) dose response curves.
Biological Mechanisms for Specific Dose Response Curves
Insights with respect to the biological mechanisms, dose response of
checkpoint arrest time and proliferation rate can be drawn from Figure 9,
which is a plot of the G1/S and G2/M checkpoint arrest time versus IR
dose; while Figure 10 depicts proliferation rate versus IR dose. Figure 11
TABLE 1. G1/S checkpoint arrest, G2/M checkpoint arrest, cell cycle time and proliferation rate. 
IRR 0 0.1 0.2 0.3 0.4 0.5 0.6
A1 (min) 0 44 74 84 90 93 93.3
A2 (min) 0 61 74 81 85 88 90
T (min) 450 555 598 615 625 631 633.3
IRD 0 55.5 119.6 184.5 250 315.5 380.0
∂N (h-1) 0.1333 0.108 0.100 0.098 0.096 0.095 0.095
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qualitatively explains the causation of the various dose response curve
shapes in the process. The arrest time in both checkpoints tends to satu-
rate when increasing IR to a certain level. The corresponding prolifera-
tion rate decreases in a sublinear manner with the increment of IR dose.
Therefore, for Case 1, when the slope of µN function is large, the value of
µN dominates the result of the product of αN and µN in low dose region,
resulting in a monotonically increasing dose response curve (Fig. 11a).
For Case 2, when the slope of µN function is moderately small, the
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FIGURE 8. Predicted dose response shapes for IR induced transformation frequency for Cases 1, 2
and 3. 
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increase of µN and decrease of αN offset each other in low dose region,
leading to a threshold dose response curve (Fig. 11b). For Case 3, when
the slope of µN function is small, the value of αN dominates the result of
the product of αN and µN in low dose region, while µN dominates the
result in high dose region in which αN tends to saturate, thus resulting in
a J-shaped dose response curve (Fig. 11c). Therefore, the J-shaped dose
response is fundamentally caused by the saturation of the checkpoint
arrest time when the dose of IR increases.
According to intermediate results, critical cell mass saturates with IR
exposure increasing. It is the fundamental mathematical reason in the
ODE system for checkpoint arrest time saturation. Under the umbrella of
systems biology approach, sophisticated mathematical methods should be
further developed to study the behavior of critical cell mass in various sit-
uations, such as for different formats of the differential equations or
under different parameter ranges. We can then obtain more insights
regarding under what biological condition, a J-shaped dose response
curve can happen.
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CONCLUSIONS
We have developed and applied computational systems biology to
investigate cancer dose response modeling through the integration of
cell cycle modeling into a two-stage clonal growth model. This model
accounts for molecular mechanisms involved in dose response and thus
is capable of exploring how transformation frequency is influenced by
cellular checkpoint arrest and associated molecular signaling network.
Hence the model includes multiple-level components of a biological sys-
tem, specifically applied to cancer from IR exposure. Furthermore,
because the direct interaction between toxicological signal and systems
biology regulator occurs at the molecular level, our model provides a
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more detailed description regarding the manner how stressors and genet-
ics interacts directly to impair one or more cellular functions and cause
adverse health effects. The newly emerging -omics technology dramati-
cally facilitates dissecting and establishing these networks. The applica-
tion of systems biology to dose response modeling is in fact a result of the
emerging omics technology.
One characteristic of computational systems biology approach is that
it uses mathematical simulation methods to assist the understanding of
complex biological system. The current study demonstrates this charac-
teristic - modular approaches enables simplification of the complicated
system to representative key elements to facilitate investigation; mathe-
matical methods allows for more insights into the underlying mecha-
nisms.
A significant contribution of this article in carcinogenic mechanism
study is that it captured the non-monotonic dose response for transfor-
mation frequency, as identified by experiments. The dominating factor
leading to the predicted non-monotonic dose responses in this model is
the increase in cell cycle time associated with activation of checkpoint
arrest. The checkpoint arrest time saturates when IR reaches a certain
level. This kind of dose response relationship is determined by the behav-
ior of toxicological signal, which directly interacts with checkpoint con-
trol regulating proteins. Our study also suggests that checkpoint arrest
can be one of the factors that lead to the non-monotonic shapes: the J-
shaped dose-response form.
A main obstacle of developing systems model is the “parameter iden-
tifiability” problem: as the number of parameters increases, many differ-
ent sets of model inputs fit the available data equally well. For example,
our “cell cycle-perturbation” sub-model has been validated by comparing
modeling with experimental results, focusing on its qualitative structure.
This required using more than a hundred parameters in the model,
which were assigned from knowledge of the biological mechanisms,
whenever possible. Although “parameter identifiability” may affect our
results, the interest of the current study is in the qualitative shape of dose
response curve, for which the mechanism (modeling structure) plays a
key role and the “parameter identifiability” problem is not a significant
factor (Conolly and Lutz, 2004). Different parameter values may shape
the dose response curve, but this reflects the influence of inter-individual
variability on the dose response (Conolly et al. 2005). This problem will
persist until sufficient data are available to identify each parameter value
and should not be an obstacle to using systems of models to ascertain
whether the LNT or the J-shape are to be used: the intervariability issue
is of secondary importance, given this need.
Our ongoing efforts are on identifying how the range of the parame-
ter values influences the behavior of the systems and the shape of the
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dose response. Finally, future study should determine how apoptosis
pathway in the model influences the endpoint of survival fraction as well
as transformation frequency through compensatory increase in cell divi-
sion rate due to cell death. A tissue-level model should also be developed
to account for intercellular communication-bystander effect. We of
course are most interested in obtaining quantitative predictions, rather
than merely describing a state of the system.
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